{
    "root": "c0e490fa-abbc-4c43-be4d-f1dd077eb0a1",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "MINOCYCLINE HYDROCHLORIDE",
    "value": "20250422",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSPOVIDONE (15 MPA.S AT 5%)",
            "code": "68401960MK"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "MINOCYCLINE HYDROCHLORIDE",
            "code": "0020414E5U"
        }
    ],
    "indications": "minocycline hydrochloride tablets , usp indicated treatment following infections due susceptible strains designated microorganisms : rocky mountain spotted fever , typhus fever typhus group , q fever , rickettsialpox tick fevers caused rickettsiae.respiratory tract infections caused mycoplasma pneumoniae . lymphogranuloma venereum caused chlamydia trachomatis . psittacosis ( ornithosis ) due chlamydophila psittaci . trachoma caused chlamydia trachomatis , although infectious agent always eliminated , judged immunofluorescence.inclusion conjunctivitis caused chlamydia trachomatis . nongonococcal urethritis , endocervical , rectal infections adults caused ureaplasma urealyticum chlamydia trachomatis . relapsing fever due borrelia recurrentis . chancroid caused haemophilus ducreyi . plague due yersinia pestis . tularemia due francisella tularensis.cholera caused vibrio cholerae.campylobacter fetus infections caused campylobacter fetus.brucellosis due brucella species ( conjunction streptomycin ) . bartonellosis due bartonella bacilliformis . granuloma inguinale caused klebsiella granulomatis . minocycline indicated treatment infections caused following gram-negative microorganisms bacteriologic testing indicates appropriate susceptibility : escherichia coli . klebsiella aerogenes shigella species . acinetobacter species . respiratory tract infections caused haemophilus influenzae . respiratory tract urinary tract infections caused klebsiella species . minocycline hydrochloride tablets , usp indicated treatment infections caused following gram-positive microorganisms bacteriologic testing indicates appropriate susceptibility : upper respiratory tract infections caused streptococcus pneumoniae . skin skin structure infections caused staphylococcus aureus . ( note : minocycline choice treatment type staphylococcal infection . ) penicillin contraindicated , minocycline alternative treatment following infections : uncomplicated urethritis men due neisseria gonorrhoeae treatment gonococcal infections.infections women caused neisseria gonorrhoeae.syphilis caused treponema pallidum subspecies pallidum.yaws caused treponema pallidum subspecies pertenue . listeriosis due listeria monocytogenes . anthrax due bacillus anthraci s.vincent ’ infection caused fusobacterium fusiforme.actinomycosis caused actinomyces israelii.infections caused clostridium species . acute intestinal amebiasis , minocycline may useful adjunct amebicides . severe acne , minocycline may useful adjunctive therapy . oral minocycline indicated treatment asymptomatic carriers neisseria meningitidis eliminate meningococci nasopharynx . order preserve usefulness minocycline treatment asymptomatic meningococcal carriers , diagnostic laboratory procedures , including serotyping susceptibility testing , performed establish carrier state correct treatment . recommended prophylactic minocycline reserved situations risk meningococcal meningitis high . oral minocycline indicated treatment meningococcal infection . although controlled efficacy conducted , limited data show oral minocycline hydrochloride used successfully treatment infections caused mycobacterium marinum . reduce development drug-resistant bacteria maintain effectiveness minocycline hydrochloride tablets , usp antibacterial drugs , minocycline hydrochloride tablets , usp used treat prevent infections proven strongly suspected caused susceptible bacteria . culture susceptibility information available , considered selecting modifying antibacterial therapy . absence data , local epidemiology susceptibility patterns may contribute empiric selection therapy .",
    "contraindications": "usual frequency minocycline differ tetracyclines . exceeding recommended may result increased incidence side effects . minocycline hydrochloride tablets may taken without food ( pharmacology ) . ingestion adequate amounts fluids along capsule tablet forms drugs tetracycline-class recommended reduce risk esophageal irritation ulceration . tablets swallowed whole .",
    "warningsAndPrecautions": "minocycline hydrochloride tablets , usp equivalent 50 mg minocycline yellow colored , oval-shaped , film-coated tablets , debossed “ ri89 ” one side plain side . supplied follows : ndc 13668-485-01 bottles 100 minocycline hydrochloride tablets , usp equivalent 75 mg minocycline yellow colored , oval-shaped , film-coated tablets , debossed “ ri90 ” one side plain side . supplied follows : ndc 13668-486-01 bottles 100 minocycline hydrochloride tablets , usp equivalent 100 mg minocycline yellow colored , oval-shaped , film-coated tablets , debossed “ ri91 ” one side plain side . supplied follows : ndc 13668-487-50 bottles 50 store 20° 25°c ( 68° 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . protect light , moisture excessive heat . dispense tight , light-resistant container child-resistant closure .",
    "adverseReactions": "contraindicated persons shown hypersensitivity tetracyclines components product formulation .",
    "indications_original": "Minocycline hydrochloride tablets, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms:\n                  Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae.Respiratory tract infections caused by Mycoplasma pneumoniae.\n                     Lymphogranuloma venereum caused by Chlamydia trachomatis.\n                     Psittacosis (Ornithosis) due to Chlamydophila psittaci.\n                     Trachoma caused by Chlamydia trachomatis, although the infectious agent is not always eliminated, as judged by immunofluorescence.Inclusion conjunctivitis caused by Chlamydia trachomatis.\n                     Nongonococcal urethritis, endocervical, or rectal infections in adults caused by Ureaplasma urealyticum or Chlamydia trachomatis.\n                     Relapsing fever due to Borrelia recurrentis.\n                     Chancroid caused by Haemophilus ducreyi.\n                     Plague due to Yersinia pestis.\n                     Tularemia due to Francisella tularensis.Cholera caused by Vibrio cholerae.Campylobacter fetus infections caused by Campylobacter fetus.Brucellosis due to Brucella species (in conjunction with streptomycin).Bartonellosis due to Bartonella bacilliformis.\n                     Granuloma inguinale caused by Klebsiella granulomatis.\n                  Minocycline is indicated for the treatment of infections caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug:\n                  \n                     Escherichia coli.\n                     \n                     Klebsiella aerogenes Shigella species.\n                     \n                     Acinetobacter species.\n                     Respiratory tract infections caused by Haemophilus influenzae.\n                     Respiratory tract and urinary tract infections caused by Klebsiella species.\n                  \n                  Minocycline hydrochloride tablets, USP are indicated for the treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug:\n                  Upper respiratory tract infections caused by Streptococcus pneumoniae.\n                     Skin and skin structure infections caused by Staphylococcus aureus. (NOTE: Minocycline is not the drug of choice in the treatment of any type of staphylococcal infection.)\n                  When penicillin is contraindicated, minocycline is an alternative drug in the treatment of the following infections:\n                  Uncomplicated urethritis in men due to Neisseria gonorrhoeae and for the treatment of other gonococcal infections.Infections in women caused by Neisseria gonorrhoeae.Syphilis caused by Treponema pallidum subspecies pallidum.Yaws caused by Treponema pallidum subspecies pertenue.\n                     Listeriosis due to Listeria monocytogenes.\n                     Anthrax due to Bacillus anthraci\n                     s.Vincent’s infection caused by Fusobacterium fusiforme.Actinomycosis caused by Actinomyces israelii.Infections caused by Clostridium species.\n                  In acute intestinal amebiasis, minocycline may be a useful adjunct to amebicides.\n                  In severe acne, minocycline may be useful adjunctive therapy.\n                  Oral minocycline is indicated in the treatment of asymptomatic carriers of Neisseria\n                     meningitidis to eliminate meningococci from the nasopharynx. In order to preserve the usefulness of minocycline in the treatment of asymptomatic meningococcal carriers, diagnostic laboratory procedures, including serotyping and susceptibility testing, should be performed to establish the carrier state and the correct treatment. It is recommended that the prophylactic use of minocycline be reserved for situations in which the risk of meningococcal meningitis is high.\n                  \n                     Oral minocycline is not indicated for the treatment of meningococcal infection.\n                  \n                  Although no controlled clinical efficacy studies have been conducted, limited clinical data show that oral minocycline hydrochloride has been used successfully in the treatment of infections caused by Mycobacterium marinum.\n                  To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride tablets, USP and other antibacterial drugs, minocycline hydrochloride tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.",
    "contraindications_original": "THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF MINOCYCLINE DIFFER FROM THAT OF THE OTHER TETRACYCLINES. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS.\n                  \n                  Minocycline hydrochloride tablets may be taken with or without food (see CLINICAL PHARMACOLOGY).\n                  Ingestion of adequate amounts of fluids along with capsule and tablet forms of drugs in the tetracycline-class is recommended to reduce the risk of esophageal irritation and ulceration. The tablets should be swallowed whole.",
    "warningsAndPrecautions_original": "Minocycline hydrochloride tablets, USP equivalent to 50 mg minocycline are yellow colored, oval-shaped, film-coated tablets, debossed with “ RI89” on one side and plain on the other side. They are supplied as follows:\n                  NDC 13668-485-01                                    Bottles of 100\n                  Minocycline hydrochloride tablets, USP equivalent to 75 mg minocycline are yellow colored, oval-shaped, film-coated tablets, debossed with “ RI90” on one side and plain on the other side. They are supplied as follows:\n                  NDC 13668-486-01                                    Bottles of 100\n                  Minocycline hydrochloride tablets, USP equivalent to 100 mg minocycline are yellow colored, oval-shaped, film-coated tablets, debossed with “ RI91” on one side and plain on the other side. They are supplied as follows:\n                  NDC 13668-487-50                                    Bottles of 50\n                  \n                     Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].\n                  \n                  \n                     Protect from light, moisture and excessive heat.\n                  \n                  \n                     Dispense in a tight, light-resistant container with child-resistant closure.",
    "adverseReactions_original": "This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines or to any of the components of the product formulation."
}